We have not identified any acquisition target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with respect to identifying any acquisition target.We will provide our stockholders with the opportunity to redeem their shares of our common stock upon the completion of our initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account described herein, including interest but net of franchise and income taxes payable, divided by the number of then outstanding shares of common stock that were sold as part of the units in this offering, which we refer to as our public shares, subject to the limitations described herein.
You should read this entire prospectus carefully, including the information under “Risk Factors” and our financial statements and the related notes included elsewhere in this prospectus, before investing.Unless otherwise stated in this prospectus, references to:•“we,” “us,” “company” or “our company” refer to Global Eagle Acquisition Corp.;•“public shares” refer to shares of our common stock sold as part of the units in this offering (whether they are purchased in this offering or thereafter in the open market);•“public stockholders” refer to the holders of our public shares, including our initial stockholders and management team to the extent our initial stockholders and/or members of our management team purchase public shares, provided that each initial stockholder’s and member of management’s status as a “public stockholder” shall only exist with respect to such public shares;•our “management” or our “management team” refer to our officers and directors;•our “sponsor” refer to Global Eagle Acquisition LLC, a Delaware limited liability company;•our “founder shares” refer to shares of our common stock initially purchased by our sponsor in a private placement prior to this offering, and all information concerning the number of founder shares or information derived from the number of founder shares gives effect to a dividend of 302,979 shares of common stock issued to our sponsor subsequent to the initial purchase of common stock by our sponsor; and•our “initial stockholders” refer to holders of our founder shares prior to this offering.Unless we tell you otherwise, the information in this prospectus assumes that the underwriters will not exercise their over-allotment option.GeneralWe are a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.
adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like).(3)Assumes no exercise of the underwriters’ over-allotment option and the resulting forfeiture of 576,220 founder shares.Warrants:Number of sponsor warrants to be sold in a private placement simultaneously with this offering7,000,000Number of warrants to be outstanding after this offering and the private placement24,500,000ExercisabilityEach warrant offered in this offering is exercisable to purchase one share of our common stock.Exercise price$11.50 per share, subject to adjustments as described herein.Exercise periodThe warrants will become exercisable on the later of:•30 days after the completion of our initial business combination, or•12 months from the closing of this offering;provided in each case that we have an effective registration statement under the Securities Act covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to them is available (or we are required to permit holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement).We are not registering the shares of common stock issuable upon exercise of the warrants at this time.
If we acquire less than 100% of the equity interests or assets of a target business or businesses, the portion of such business or businesses that we acquire is what will be valued for purposes of the 80% of net assets test.Permitted purchases of public shares by us prior to the completion of our initial business combination using amounts held in the trust accountUnlike many blank check companies, if we seek stockholder approval of our initial business combination and we do not conduct redemptions in connection with our business combination pursuant to the tender offer rules, prior to the completion of a business combination, our amended and restated certificate of incorporation will permit the release to us from the trust account amounts necessary to purchase up to 50% of the shares sold in this offering (8,750,000 shares, or 10,062,500 shares if the underwriters’ over-allotment option is exercised in full) at any time commencing after the filing of a preliminary proxy statement for our initial business combination and ending on the date of the stockholder meeting to approve the initial business combination.
If, nevertheless, such an amendment is approved by our stockholders, we will provide our public stockholders with the opportunity to redeem their shares of common stock upon such approval at a per-share price, payable in cash, equal to the aggregate amount then on18TABLE OF CONTENTSdeposit in the trust account, including interest but net of franchise and income taxes payable, divided by the number of then outstanding public shares.Limited payments to insidersThere will be no finder’s fees, reimbursements or cash payments made to our sponsor, officers, directors, or our or their affiliates, for services rendered to us prior to or in connection with the completion of our initial business combination, other than the following payments, none of which will be made from the proceeds of this offering held in the trust account prior to the completion of our initial business combination (except to the extent paid out of up to $1,750,000 subject to adjustment as described herein of interest earned on the trust account that may be released to us to fund working capital requirements):•Repayment of loans of up to an aggregate of $200,000 made to us by our sponsor to cover offering-related and organizational expenses;•A payment of an aggregate of $10,000 per month to Roscomare Ltd., an entity owned and controlled by Mr. Sloan, our chairman and chief executive officer, for office space, secretarial and administrative services;•Consulting fees payable to our chief financial officer, James A.
(approximately $8,050,000 if the underwriters’ over-allotment option is exercised in full) representing deferred underwriting commissions.If no business combination is completed within 21 months from the closing of this offering, the proceeds held in the trust account, including the deferred underwriting commissions and all interest thereon, net of franchise and income taxes payable, up to $100,000 of such net interest that may be released to us to pay dissolution expenses, any interest income released to us to fund our working capital requirements and any amounts released to purchase up to 50% of our public shares if we seek stockholder approval of our business combination, as described in this prospectus, will be used to fund the redemption of our public shares.
See “Proposed Business—Business Strategy—Tendering stock certificates in connection with a tender offer or redemption rights.”Our purchase of common stock in the open market may support the market price of the common stock and/or warrants during the buyback period and, accordingly, the termination of the support provided by such purchases may materially adversely affect the market price of the units, common stock and/or warrants.Unlike many blank check companies, if we seek stockholder approval of our initial business combination, prior to the completion of a business combination, our amended and restated certificate of incorporation will permit the release to us from the trust account amounts necessary to purchase up to 50% of the shares sold in this offering (8,750,000 shares, or 10,062,500 shares if the over-allotment option is exercised in full) at any time commencing after the filing of a preliminary proxy statement for our initial business combination and ending on the date of the stockholder meeting to approve the initial business combination.